VRTX logo

Vertex Pharmaceuticals Inc

VRTX

VRTX: Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

more

Show VRTX Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of VRTX by members of U.S. Congress

Politician Type Traded
Tuberville, Tommy Senate / R Purchase $1,001 - $15,000 Oct. 06, 2022
William R. Keating House / D Purchase $1,001 - $15,000 Mar. 29, 2022
Mr. Peter Meijer House / R Sale $1,001 - $15,000 Jan. 28, 2021
Dean Phillips House / D Purchase $1,001 - $15,000 Dec. 18, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep. 19, 2019
Donna Shalala House / D Sale $1,001 - $15,000 Jun. 24, 2019
Donna Shalala House / D Purchase $1,001 - $15,000 Apr. 18, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Apr. 11, 2019
Gilbert Cisneros House / D Sale $15,001 - $50,000 Feb. 27, 2019
Gilbert Cisneros House / D Sale $15,001 - $50,000 Feb. 26, 2019
Reed, John F. Senate / D Sale (Full) $1,001 - $15,000 Feb. 04, 2019
Gilbert Cisneros House / D Sale $1,001 - $15,000 Jan. 31, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Jun. 01, 2018
Josh Gottheimer House / D Sale $1,001 - $15,000 May. 01, 2018
Reed, John F. Senate / D Sale (Partial) $1,001 - $15,000 Mar. 09, 2018
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jul. 19, 2017
Josh Gottheimer House / D Purchase $1,001 - $15,000 Apr. 13, 2017
Thomas Macarthur House / R Purchase $1,001 - $15,000 Nov. 02, 2016
Thomas Macarthur House / R Purchase $1,001 - $15,000 Nov. 01, 2016
K. Michael Conaway House / R Sale $1,001 - $15,000 Sep. 12, 2016
Thomas Macarthur House / R Sale $1,001 - $15,000 Feb. 02, 2016
Reed, John F. Senate / D Sale (Partial) $1,001 - $15,000 May. 13, 2015
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by VRTX's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $630,000 Jul 19, 2023 Issue: Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Health Issues
  • $670,000 Apr 19, 2023 Issue: Medicare/Medicaid Budget/Appropriations Taxation/Internal Revenue Code Health Issues
  • $370,000 Jan 18, 2023 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Taxation/Internal Revenue Code Health Issues
  • $710,000 Oct 14, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Taxation/Internal Revenue Code Health Issues
  • $520,000 Jul 19, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $520,000 Apr 20, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $630,000 Jan 20, 2022 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $450,000 Oct 20, 2021 Issue: Health Issues Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid
  • $420,000 Jul 19, 2021 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $570,000 May 21, 2021 Issue: Health Issues Medicare/Medicaid
  • $410,000 Apr 19, 2021 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $380,000 Oct 20, 2020 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $380,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $390,000 Apr 20, 2020 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $530,000 Jan 21, 2020 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $310,000 Oct 21, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $310,000 Jul 22, 2019 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $320,000 Apr 19, 2019 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $450,000 Jan 21, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $340,000 Oct 19, 2018 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $350,000 Jul 18, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $350,000 Apr 19, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $340,000 Jan 19, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $340,000 Oct 19, 2017 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $560,000 Jul 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $450,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $340,000 Jan 20, 2017 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $350,000 Oct 20, 2016 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $440,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Apr 20, 2016 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $350,000 Jan 19, 2016 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $330,000 Oct 20, 2015 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $300,000 Jul 20, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $380,000 Apr 20, 2015 Issue: Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid
  • $210,000 Jan 19, 2015 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $280,000 Oct 16, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $480,000 Jul 21, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $190,000 Apr 21, 2014 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues
  • $210,000 Jan 20, 2014 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $210,000 Oct 21, 2013 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $460,000 Jul 18, 2013 Issue: Health Issues
  • $300,000 Apr 22, 2013 Issue: Health Issues
  • $260,000 Jan 22, 2013 Issue: Budget/Appropriations Health Issues
  • $250,000 Oct 19, 2012 Issue: Health Issues Budget/Appropriations
  • $360,000 Jul 20, 2012 Issue: Budget/Appropriations Health Issues
  • $490,000 Apr 20, 2012 Issue: Health Issues Budget/Appropriations
  • $480,000 Jan 19, 2012 Issue: Health Issues Budget/Appropriations
  • $360,000 Oct 20, 2011 Issue: Health Issues Budget/Appropriations
  • $450,000 Jul 19, 2011 Issue: Health Issues
  • $460,000 Apr 20, 2011 Issue: Health Issues
  • $140,000 Jan 19, 2011 Issue: Health Issues
  • $370,000 Oct 20, 2010 Issue: Health Issues
  • $170,000 Jul 20, 2010 Issue: Health Issues
  • $300,000 Apr 20, 2010 Issue: Health Issues
  • $120,000 Jan 20, 2010 Issue: Health Issues
  • $130,000 Oct 20, 2009 Issue: Health Issues
  • $130,000 Jul 20, 2009 Issue: Health Issues
  • $180,000 Apr 20, 2009 Issue: Health Issues
  • $100,000 Jan 21, 2009 Issue: Health Issues
  • $120,000 Oct 20, 2008 Issue: Health Issues
  • $80,000 Jul 21, 2008 Issue: Health Issues
  • $80,000 Apr 21, 2008 Issue: Science/Technology Medical/Disease Research/Clinical Labs Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Health Issues
U.S. Patents

New patents grants

  • Patent Title: Processes for making modulators of cystic fibrosis transmembrane conductance regulator Jul. 25, 2023
  • Patent Title: Pyridone amides as modulators of sodium channels Jun. 13, 2023
  • Patent Title: Modulators of atp-binding cassette transporters May. 02, 2023
  • Patent Title: Mannose derivatives for treating bacterial infections Apr. 25, 2023
  • Patent Title: Pyrrole inhibitors of erk protein kinase, synthesis thereof and intermediates thereto Apr. 25, 2023
  • Patent Title: Modulators of alpha-1 antitrypsin Apr. 11, 2023
  • Patent Title: Inhibitors of apol1 and methods of using same Apr. 04, 2023
  • Patent Title: Modified urokinase-type plasminogen activator polypeptides and methods of use Mar. 28, 2023
  • Patent Title: Carboxamides as modulators of sodium channels Mar. 14, 2023
  • Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator Feb. 28, 2023
  • Patent Title: Process of making cftr modulators Feb. 21, 2023
  • Patent Title: Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide Feb. 14, 2023
  • Patent Title: Pteridinone compounds and uses thereof Feb. 07, 2023
  • Patent Title: Pharmaceutical composition and administrations thereof Jan. 31, 2023
  • Patent Title: Materials and methods for treatment of hemoglobinopathies Jan. 31, 2023
  • Patent Title: Method of treating pain Dec. 20, 2022
  • Patent Title: Stem cell derived islet differentiation Dec. 13, 2022
  • Patent Title: Methods of treatment for cystic fibrosis Dec. 06, 2022
  • Patent Title: Compounds useful as inhibitors of atr kinase Nov. 01, 2022
  • Patent Title: Devices and methods for delivering therapeutics Oct. 18, 2022
  • Patent Title: Processes for making modulators of cystic fibrosis transmembrane conductance regulator Oct. 11, 2022
  • Patent Title: Method for treating cancer using a combination of dna damaging agents and atr inhibitors Oct. 11, 2022
  • Patent Title: Stem cell derived islet differentiation Oct. 11, 2022
  • Patent Title: Materials and methods for treatment of pain related disorders Oct. 04, 2022
  • Patent Title: Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Sep. 27, 2022
  • Patent Title: Processes for preparing pyrrolidine compounds Sep. 06, 2022
  • Patent Title: Materials and methods for treatment of myotonic dystrophy type 1 (dm1) and other related disorders Aug. 30, 2022
  • Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator Aug. 30, 2022
  • Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Aug. 16, 2022
  • Patent Title: Materials and methods for treatment of duchenne muscular dystrophy Jun. 28, 2022
  • Patent Title: Compounds useful as inhibitors of atr kinase Jun. 28, 2022
  • Patent Title: Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels Jun. 14, 2022
  • Patent Title: Methods of preparing inhibitors of influenza viruses replication May. 31, 2022
  • Patent Title: Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Apr. 05, 2022
  • Patent Title: Materials and methods for treatment of hemoglobinopathies Mar. 08, 2022
  • Patent Title: Methods of treatment for cystic fibrosis Feb. 22, 2022
  • Patent Title: Sulfonamides as modulators of sodium channels Dec. 21, 2021
  • Patent Title: Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Nov. 30, 2021
  • Patent Title: Pharmaceutical compositions for treating cystic fibrosis Nov. 23, 2021
  • Patent Title: Method for treating cancer using a combination of chk1 and atr inhibitors Nov. 23, 2021
  • Patent Title: Crystalline forms and compositions of cftr modulators Oct. 26, 2021
  • Patent Title: Pharmaceutical composition and administrations thereof Oct. 19, 2021
  • Patent Title: Methods, compositions and kits for increasing genome editing efficiency Sep. 21, 2021
  • Patent Title: Compounds useful as inhibitors of atr kinase Sep. 14, 2021
  • Patent Title: Method for treating cancer using a combination of dna-damaging agents and dna-pk inhibitors Sep. 07, 2021
  • Patent Title: Compounds useful as inhibitors of atr kinase and combination therapies thereof Sep. 07, 2021
  • Patent Title: Modulators of atp-binding cassette transporters Aug. 10, 2021
  • Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators Jul. 20, 2021
  • Patent Title: Pteridinone compounds and uses thereof Jul. 13, 2021
  • Patent Title: Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof Jul. 06, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of VRTX in WallStreetBets Daily Discussion

VRTX News

Recent insights relating to VRTX

CNBC Recommendations

Recent picks made for VRTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VRTX

Corporate Flights

Flights by private jets registered to VRTX